Sergio Traversa, CEO at RELMADA THERAPEUTICS, INC. (RLMD), sold 5,806 shares at $35.44 ($206K) on 2021-01-22, disclosed to the SEC on 2021-01-26.
Open-market sale of $206k RLMD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.44 | 1,736 | $62K | 29.9% |
| 2 | $35.44 | 1,736 | $62K | 29.9% |
| 3 | $36.15 | 434 | $16K | 7.6% |
| 4 | $35.29 | 1,300 | $46K | 22.3% |
| 5 | $35.15 | 600 | $21K | 10.3% |
| Total | $35.43 avg | 5,806 |
| $206K |
| 100% |
| Filing → |
| RLMD | BUY | 2025-11-06 | $600K | — | Filing → |
| RLMD | BUY | 2025-08-28 | $265K | — | Filing → |
| RLMD | BUY | 2025-05-20 | $335K | — | Filing → |